Research Type: Extramural
Dr Megan Chircop’s team have found new compounds that can target the deadliest type of malignant brain tumour, glioblastoma multiforme.
Jane Bennett talks about representing consumers in deciding what research Cancer Council funds.
For Phil, the highlight of being on the Consumer Review Panel is seeing the variety of different research proposals Cancer Council NSW receives on many different types of cancer.
The aim of this 5 year program is to increase survival rates of children with Acute Lymphoblastic Leukaemia (ALL) and ultimately develop prevention strategies.
A/Prof Claire Wakefield is testing interventions that provide support and improve long term outcomes to childhood cancer survivors and their families.
Professor Wiggers is evaluating community programs and how well they reduce modifiable lifestyle risk factors for cancer.
Professor Minoti Apte and her team made a crucial breakthrough in finding that the cells around the pancreas help the tumour to grow. Targeting these cells can hinder growth of the cancer.
A diagnosis of pancreatic cancer 18 years ago drove Jan to improve her understanding of cancer. She now sits on our Research Consumer Review Panel, helping decide which research we fund.
Professor Christopher Ormandy is driving the next generation of revolutionary breast cancer treatments. His team has identified pathways that turn normal breast cells into cancer.
Professor Robyn Ward and her team have discovered new causes of the hereditary condition, Lynch syndrome, which makes people more likely to get certain cancers.